SPE Capital Partners (“SPE Capital”) today announced the final close of SPE AIF I, an Africa-focused private equity fund. SPE AIF I was oversubscribed and closed…
SPE Capital is pleased to announce that Stéphane Heuzé has joined the firm as a Managing Partner, to be based out of the Casablanca office.
SPE AIF I and Proparco acquire Saham Pharma, a leading antibiotics manufacturer and major hospital provider in Morocco
SPE AIF I invests in H&S Invest Holding Group, the leading fully integrated FMCG distributor in Morocco
SPE AIF I invests in Future Pharmaceutical Industries, a fast-growing Egyptian generic pharmaceuticals manufacturer
SPE Capital successfully completes a dividend recapitalization, partial exit and capital increase in relation to its investment in Sotipapier
SPE Capital successfully exits its investment in Orchidia Pharmaceutical Industries